Chronic hypertension screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The Joint National Committee seventh report (JNC 7) defines hypertension as a [[systolic blood pressure]] of over 140 mm Hg or a [[diastolic blood pressure]] greater than 90 mm Hg based upon the average of two or more properly measured readings at each of two or more visits after an initial screen<ref name="pmid12748199">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal=JAMA | year= 2003 | volume= 289 | issue= 19 | pages= 2560-72 | pmid=12748199 | doi=10.1001/jama.289.19.2560 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12748199}}</ref>. | The Joint National Committee seventh report (JNC 7) defines hypertension as a [[systolic blood pressure]] of over 140 mm Hg or a [[diastolic blood pressure]] greater than 90 mm Hg based upon the average of two or more properly measured readings at each of two or more visits after an initial screen<ref name="pmid12748199">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal=JAMA | year= 2003 | volume= 289 | issue= 19 | pages= 2560-72 | pmid=12748199 | doi=10.1001/jama.289.19.2560 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12748199}}</ref>. | ||
==Screening test for identifiable Hypertension== | |||
{|style="width:80%; height:100px" border="1" | |||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Diagnosis''' | |||
|style="height:100px"; style="width:75%" border="1" bgcolor="LightSteelBlue" | '''Diagnostic Tests''' | |||
|- | |||
|-bgcolor="Beige" | |||
| [[Chronic kidney disease]] | |||
|bgcolor="Beige"| Estimate [[GFR]] | |||
|- | |||
|-bgcolor="Beige" | |||
| [[Coarctation of aorta]] | |||
|bgcolor="Beige"| CT angiography | |||
|- | |||
|-bgcolor="Beige" | |||
| [[Cushing's syndrome]] and other [[glucocorticoid]] excess states including chronic steroid therapy | |||
|bgcolor="Beige"| History; [[dexamethasone suppression test]] | |||
|- | |||
|-bgcolor="Beige" | |||
| Drug induced/related | |||
|bgcolor="Beige"| History; drug screening | |||
|- | |||
|-bgcolor="Beige" | |||
| [[Pheochromocytoma]] | |||
|bgcolor="Beige"| 24 hour urinary metanephrine and normetanephrine | |||
|- | |||
|-bgcolor="Beige" | |||
| Primary [[aldosteronism]] and other [[mineralocorticoid]] 24-hour urinary [[aldosterone]] level or excess states | |||
|bgcolor="Beige"| 24-hour urinary [[aldosterone]] level or specific measurements of other mineralocorticoids | |||
|- | |||
|-bgcolor="Beige" | |||
| Renovascular hypertension | |||
|bgcolor="Beige"| Doppler flow study; magnetic resonance angiography | |||
|- | |||
|-bgcolor="Beige" | |||
| [[Sleep apnea]] | |||
|bgcolor="Beige"| Sleep study with O2 saturation | |||
|- | |||
|-bgcolor="Beige" | |||
| [[Thyroid]]/ [[Parathyroid]] disease | |||
|bgcolor="Beige"| [[TSH]]; serum [[PTH]] | |||
|} | |||
==References== | ==References== | ||
Revision as of 15:39, 4 October 2012
|
Hypertension Main page |
Overview
The Joint National Committee seventh report (JNC 7) defines hypertension as a systolic blood pressure of over 140 mm Hg or a diastolic blood pressure greater than 90 mm Hg based upon the average of two or more properly measured readings at each of two or more visits after an initial screen[1].
Screening test for identifiable Hypertension
| Diagnosis | Diagnostic Tests |
| Chronic kidney disease | Estimate GFR |
| Coarctation of aorta | CT angiography |
| Cushing's syndrome and other glucocorticoid excess states including chronic steroid therapy | History; dexamethasone suppression test |
| Drug induced/related | History; drug screening |
| Pheochromocytoma | 24 hour urinary metanephrine and normetanephrine |
| Primary aldosteronism and other mineralocorticoid 24-hour urinary aldosterone level or excess states | 24-hour urinary aldosterone level or specific measurements of other mineralocorticoids |
| Renovascular hypertension | Doppler flow study; magnetic resonance angiography |
| Sleep apnea | Sleep study with O2 saturation |
| Thyroid/ Parathyroid disease | TSH; serum PTH |
References
- ↑ Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL; et al. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199.